Exeltis
Manufacturing · New Jersey, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
180 Park Ave Ste 101, Florham Park, New ...Phone Number
(973) 324-0200Website
www.exeltisusa.comRevenue
$726.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
5
1
1
1
1
About Exeltis
Exeltis is a fast-growing division of Madrid-based Insud Pharma, an integrated health sciences group. It has developed a leading position in the women's health sector, where it continues to discover, develop, produce and seek new medicines and medical devices to improve the health and wellbeing of women around the world. Exeltis strives to provide care for women throughout their lives. Exeltis offers a broad portfolio of products to respond to patients' needs in Women's Health including contraception, pregnancy, birth, and menopause and has expanded its research in recent years to Central Nervous System (CNS), ophthalmology and endocrinology.Explore more
Exeltis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Exeltis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Exeltis has recently received funding, and reach out quickly before it becomes old news!
Exeltis, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Exeltis
Funding: Get notified immidiatlly once Exeltis has new funding data
Click to see if Exeltis had a recent Job posting/layoffs
Product Launch: Get notified when Exeltis launches new products
Check out if Exeltis is spiking on competitors!
Earning: See what the market has to say on Exeltis recently announced quarterly report
Recommended Actions
Find VP level buyers at Exeltis
Find 3 more new buyers
Compare Similar Companies to Exeltis
Compare insights from companies similar to Exeltis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Exeltis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Exeltis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Exeltis.
Exeltis Tech Stack
A closer look at the technologies used by Exeltis
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Hiring Plans
Exeltis is hiring in Medical & Health for the first time in 12 months with an increased focus that include Clinical Trial Planning, and Medical Affairs.
Hiring Plans
Open Position
Exeltis News & Media
Exeltis USA, Inc. Sparks National Conversation About Health Equity, Inclusion and Body Positivity During Women’s Health Month with “Let’s Love Every Body” Campaign
FLORHAM PARK, N.J.--(BUSINESS WIRE)-- #LetsLoveEveryBody--Exeltis USA, Inc., a division of the global pharmaceutical group Insud Pharma, today announced “Let’s Love Every Body,” a national campaign designed to empower women to live life to the fullest while loving and accepting their bodies. The campaign features real stories from women of diverse body types, ages and cultural backgrounds discussing the need for every body (and everybody) to be loved, respected and welcomed in more spaces, especExeltis USA, Inc. Launches Blues Away®, a First-of-its-Kind Postpartum Mood Support Dietary Supplement* for New Mothers Experiencing Postpartum Blues
FLORHAM PARK, N.J.--(BUSINESS WIRE)--Exeltis USA launches Blues Away®. Blues Away® is a first-of-its-kind single, 3-day shake regimen available without a prescription.Luye Pharma Grants Exeltis Exclusive Commercialization Rights to Its Innovative Alzheimer's Disease Treatment Rivastigmine Multi-Day Transdermal Patch in Mexico and Poland
BASEL, Switzerland, March 31, 2022 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today announced that its subsidiary Luye Pharma Switzerland AG has entered into agreements with Exeltis Pharma México, S.A. de C.V and Exeltis Pharmaceuticals Holding, S.L (Exeltis), under which the company...Lupin Signs Promotional Agreement with Exeltis on SOLOSEC® (secnidazole) expanding access for Adult Women Suffering with Bacterial Vaginosis and Adults with Trichomoniasis
BALTIMORE, Jan. 27, 2022 /PRNewswire/ -- Lupin Pharmaceuticals Inc., (Lupin), and Exeltis USA Inc. announced a promotional agreement for Exeltis to promote SOLOSEC® along with Exeltis' existing line of Women's Health products, further enhancing value to OBGYNs and their patients. SOLOSEC®...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Exeltis
Sign Up For FreeTo access detailed company insights
Exeltis is a fast-growing division of Madrid-based Insud Pharma, an integrated health sciences group. It has developed a leading position in the women's health sector, where it continues to discover, develop, produce and seek new medicines and medical devices to improve the health and wellbeing of women around the world. Exeltis strives to provide... Read More
